Jan 13 (Reuters) - Verastem Inc :
* VERASTEM ONCOLOGY ANNOUNCES DEBT REFINANCING WITH OBERLAND CAPITAL AND STRATEGIC COMMERCIALIZATION PARTNERSHIP WITH IQVIA TO SUPPORT POTENTIAL LAUNCH IN RECURRENT KRAS MUTANT LOW-GRADE SEROUS OVARIAN CANCER IN MID-2025
* VERASTEM INC - SECURES $150 MILLION CREDIT FACILITY AND $7.5 MILLION EQUITY INVESTMENT
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.